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Case–control studies have shown inverse associations between cigarette smoking and endometrial cancer risk. However, two
small prospective cohort studies have not clearly supported an association. Moreover, quantitative measures of smoking have
been examined infrequently. Our aim was to study the association between smoking and endometrial cancer risk in a large
prospective cohort. We used proportional hazards models to estimate hazard ratios relating cigarette smoking to endometrial
cancer risk among 70591 women aged 40–59 years at recruitment into a randomised controlled trial of mammography
screening for breast cancer. During an average of 10.6 years of follow-up (751833 person–years), a total of 403 women
were diagnosed with incident endometrial cancer. We found that a reduced endometrial cancer risk was evident only among
women who currently smoked 20 cigarettes per day or more (hazard ratio=0.62, 95% CI=0.42–0.92, P for trend=0.03).
There was some suggestion of an inverse association with smoking duration, but this was less clear. The association did not
vary with menopausal status, relative body weight, or the use of hormone replacement therapy, but it appeared to be
stronger among parous than nulliparous women. The underlying biological mechanisms of this association remain unclear.
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Endometrial cancer is the most commonly diagnosed cancer of the
female genital tract in developed countries (Parker et al, 1997).
Cigarette smoking has been associated inversely with endometrial
cancer risk, but only in case–control studies. Although the
mechanism through which smoking may reduce risk is unknown,
it has been postulated that it might occur through a reduction in
the gastrointestinal absorption or distribution of oestrogen, or
through increased hepatic metabolism of oestrogen, oestrogen
being one of the few known risk factors for this malignancy
(Baron, 1984).
Although the number of studies that address this issue is grow-
ing, many aspects of the relationship between cigarette smoking
and endometrial cancer risk remain under-explored. For example,
most previous studies have not directly examined smoking inten-
sity or smoking duration in relation to endometrial cancer risk.
The examination of these smoking measures is important, since
potentially deleterious effects of the many carcinogens contained
in tobacco smoke (IARC, 1986; Hoffmann and Hoffmann, 1997)
may be observed only with smoking of long duration, such as with
cancers of the colorectum (Giovannucci, 2001), or with smoking of
high intensity. Furthermore, if a dose-response association with
cigarette smoking can be demonstrated with increasing levels of a
particular smoking measure, the role of smoking in endometrial
cancer etiology may be established more ﬁrmly.
Prospective cohort studies of smoking and endometrial cancer
risk, in which the problems of selection and recall bias are mini-
mised, have been scarce. Indeed, the only two such studies
(Engeland et al, 1996; Terry et al, 1999) were relatively small and
uninformative. We have therefore examined the relation between
cigarette smoking and risk of endometrial cancer in a cohort of
women with up to four decades of smoking duration at recruit-
ment, who were subsequently followed for an average of 10.6 years.
SUBJECTS AND METHODS
Study population
The investigation was conducted using data from the Canadian
National Breast Screening Study (NBSS). The NBSS is a multi-
centre randomised controlled trial of mammography screening
for breast cancer in 89835 women aged 40–59 years at recruitment
(Miller et al, 1992). Participants were recruited between 1980 and
1985 by various means, including personal invitation by letter,
group mailings to employees of large institutions and to members
of professional associations, advertisements in newspapers, and
public service announcements on radio and television.
Questionnaires
On enrolment in the NBSS, all participants completed a self-admi-
nistered questionnaire that sought data on demographic
characteristics, lifestyle (including cigarette smoking), menstrual
and reproductive history, use of oral contraceptives and replace-
ment oestrogens. Regarding smoking history, participants were
ﬁrst asked whether or not they had ever smoked. Women who
had smoked were then asked how many cigarettes they smoked
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had ceased smoking (former smokers only). Starting in 1982, a
questionnaire regarding diet and physical activity was distributed
to all new attendees at all screening centres, and to women return-
ing to the screening centres for re-screening (Jain et al, 1982). By
the time that the dietary questionnaire was introduced, some
women had already been enrolled in the study and were not seen
again at the screening centres. A total of 56837 women returned
completed dietary questionnaires. Therefore, to assess the possibi-
lity of residual confounding among women with missing
information on alcohol consumption and physical activity, analyses
were performed both on the entire cohort and among women for
whom information on alcohol and physical activity was available
(see below).
Cohort and case deﬁnition and ascertainment of outcome
Women were eligible for inclusion in the cohort if, at recruitment,
they had neither a history of endometrial cancer nor a history of
hysterectomy. On this basis, 19158 women (19049 with history
of hysterectomy, 109 with a history of endometrial cancer) were
excluded, as were 86 women for whom no smoking information
was available, and follow-up was based on the cohort of 70591
women with intact uteri and with no history of endometrial cancer.
Four hundred and three women with incident endometrial cancer
were identiﬁed during the follow-up period. Cases of incident
endometrial cancer and deaths were ascertained respectively
through computerised record linkage to the Canadian Cancer
Database and the National Mortality Database, both of which are
maintained by Statistics Canada. There is good evidence from the
NBSS and from other sources that the use of record linkage to
ascertain incident cancer cases and deaths in Canada is both accu-
rate and complete (Robles et al, 1988; Shannon et al, 1989).
Statistical analysis
Follow-up of the cohort was continued until the date of diagnosis of
endometrial cancer, the date of death, or the end of the follow-up
period (December 31, 1993), whichever was the earliest. Cox propor-
tional hazards models were used to estimate hazard ratios (RR) and
95% conﬁdence intervals (CI) for the association between smoking
and endometrial cancer risk. Age at smoking commencement was
calculated for each smoker by subtracting her total years of smoking
(and the time since quitting for ex-smokers) from her age at recruit-
ment. Multivariate models included age in 5-year age groups,
Quetelet’s index (quartiles), education level (less than high school,
high school, and university), vigorous physical activity (hours per
day in tertiles, and ‘missing’), hormone replacement therapy (never
+ four levels of duration), oral contraceptive use (never + four levels
of duration), menopausal status (pre, peri, post at recruitment),
parity (nulliparous, and tertiles), and alcohol consumption (tertiles,
and ‘missing’). Alcohol consumption and physical activity were cate-
gorised by tertiles or as ‘missing,’ where the latter group was
comprised of women who did not complete the questionnaire
regarding physical activity and diet. The lowest tertile of alcohol
consumption was comprised of non-drinkers. To assess the possibi-
lity of residual confounding among women with missing
information on alcohol consumption and physical activity, we
conducted additional analyses limited to the 44525 women (includ-
ing 257 cases) who completed questionnaires regarding diet and
physical activity and who did not have a history of hysterectomy.
For tests of trend in risk across successive levels of categorical vari-
ables, median values of each category were ﬁtted into the risk
models as successive integers (Rothman and Greenland, 1998).
Analyses were conducted overall and within strata deﬁned by
menopausal status, obesity, and exogenous hormone use. Women
who, at recruitment, reported having had regular menstrual periods
within the past 12 months were considered to be premenopausal,
while those in whom menstrual periods had ceased at least 12
months before baseline assessment (or before recruitment) were
considered to be postmenopausal, as were women who had
previously undergone oophorectomy (with or without a history
of hysterectomy). For the purposes of stratiﬁed analyses with
respect to obesity, women were categorised according to criteria
for obesity established by the World Health Organisation,
(WHO, 1997) namely ‘pre-obese’ (BMI 25.07530 kg m
72) and
‘obese’ (BMI 530 kg m
72); those with a BMI 525.0 kg m
72
were classiﬁed as ‘non-obese.’
RESULTS
On average, participants were followed for 10.6 years, yielding a
total of 751833 person-years of follow-up for the cohort. The aver-
age age at diagnosis of endometrial cancer was 57.4 years. Current
smokers had the lowest median BMI, were the least likely to have
completed secondary education, had the greatest percentage of
hormone replacement therapy, were most likely to be postmeno-
pausal, and along with former smokers had a higher percentage
of oral contraceptive use and alcohol consumption than never
smokers (Table 1). There were no clear differences by smoking
status with respect to age, parity, or vigorous physical activity.
Current smokers had a 23% reduced risk of endometrial cancer
after adjusting for the effect of age only, which was moderately
attenuated by the addition of Quetelet’s Index (kg m
72) to the
model (Table 2). The addition of other covariates to the model
did not alter the rate ratios appreciably. No altered risk was
observed among ex-smokers.
Multivariate-adjusted rate ratios for various measures of cigar-
ette smoking are shown in Table 3 for former and current
smokers separately. The absence of an association among former
smokers did not vary according to the total years or pack-years
smoked, the number of cigarettes smoked per day, or with years
since smoking ceased. Among current smokers, however, a reduced
endometrial cancer risk was evident only among women who
smoked 20 cigarettes per day or more; there was some suggestion
of an inverse association with smoking duration, but this was less
clear. In further analyses amongst current smokers, when smoking
duration (1–19 and 20+ years, respectively) was examined over
strata of smoking intensity (1–19 and 20+ cigarettes per day,
respectively), a statistically signiﬁcant 40% reduction in risk was
observed only among women who were both long-term and heavy
smokers RR=0.63, 95%CI=0.42–0.96). In current smokers, pack-
years of consumption, the product of smoking duration and inten-
sity, was inversely associated with endometrial cancer risk with a
magnitude that was intermediate between those observed for the
two latter measures (Table 3). There was a statistically non-signiﬁ-
cant 30% reduction in risk with commencement of smoking at age
15 or earlier (data not shown).
Among current smokers, the association between smoking inten-
sity and endometrial cancer risk did not vary appreciably according
to menopausal status, relative body weight, history of oral contra-
ceptive use, or hormone replacement therapy (Table 4). Similarly,
the association between smoking duration and risk did not vary
over strata of these variables (data not shown). However, while
there was an inverse association between smoking intensity and
endometrial risk among parous current smokers, there was no
association among nulliparous women, either with smoking inten-
sity or duration, although the number of cases among nulliparous
women was low (n=74) and the conﬁdence intervals were wide. On
formal testing, an interaction between smoking and parity in rela-
tion to endometrial cancer risk was not detected. The association
between smoking and endometrial cancer risk did not vary accord-
ing to levels of physical activity or alcohol consumption (data not
shown). Among ex-smokers, there was no clear association with
any of the smoking variables in any of the strata of the factors that
were examined.
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the analyses were performed among the 44525 women for whom
alcohol consumption and physical activity data were available (data
not shown); these women were similar to the remainder of the
cohort with respect to the variables included in the multivariate
models. The results were also largely unaltered after excluding cases
that occurred within the ﬁrst year of follow-up, thereby reducing
the likelihood that changes in smoking habits due to pre-clinical
undiagnosed endometrial cancer might have inﬂuenced our results.
DISCUSSION
In our large prospective cohort study, we found that current
smokers, but not former smokers, had a reduced risk of endome-
trial cancer. The inverse association among current smokers
appeared to be conﬁned to women who smoked one packet of
cigarettes per day or more, a group which had also mainly smoked
for 20 years or longer. The approximately 40% reduced risk among
these women compared with never smokers did not vary appreci-
ably according to strata deﬁned by menopausal status, relative body
weight, or exogenous hormone use, but the association appeared to
be stronger among parous than nulliparous women. Our results
suggest that a reduced relative body weight among current
smokers, compared to never smokers and former smokers, explains
some, but not all, of the inverse association between smoking and
endometrial cancer risk. Although most studies have not speciﬁ-
cally examined the contribution of body mass index (BMI) to
the association between smoking and endometrial cancer risk, a
recent case–control study (Weiderpass and Baron, 2001) found
that adjustment for BMI attenuated the relative risk estimates for
current smoking only slightly.
Among the strengths of our study was the large sample size
of our cohort of women and the relatively long-term follow-up.
The completeness of follow-up of the cohort (Robles et al,
1988; Shannon et al, 1989) reduces the likelihood that our
results reﬂect bias due to differential follow-up of long-term
smokers compared with non-smokers. However, we did not
have information on hysterectomy occurrence during follow-
up. Given the 20–130% higher risk of hysterectomy among
smokers compared with non-smokers observed in a recent
study (Harlow and Barbieri, 1999), a greater proportion of
smokers than non-smokers would have continued to be
followed (and to have contributed follow-up time) after they
were no longer at risk of endometrial cancer, which would
erroneously have lowered the rate of disease among smokers
and biased results towards the ﬁnding of an inverse association.
However, the estimated rate of hysterectomy in Canada at the
time of follow-up was 62 per 10000 person-years (Wijma et al,
1984), which, if unaccounted for, would have resulted in a
relative inﬂation of person-time for smokers of approximately
5%. Correction for this in our data, using the estimate of
130% higher risk of hysterectomy among the heaviest smokers
(Harlow and Barbieri, 1999), resulted in a change in the rate
ratio for smoking 20 cigarettes per day or more from 0.62
to 0.65, a negligible difference. Finally, although we did adjust
our estimates for a wide range of potentially confounding vari-
ables, we cannot exclude the possibility of residual confounding
by other factors.
Factors that inﬂuence circulating levels of oestrogen are
among the few established risk factors for endometrial cancer
(Akhmedkhanov et al, 2001). These factors include a high
relative body weight, low parity, and oestrogen replacement
therapy. Oestrogen is thought to increase the risk by increas-
ing the mitotic activity of endometrial cells, increasing the
number of DNA replication errors, and by inducing somatic
mutations resulting in the malignant phenotype (Akhmedkha-
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Table 1 Baseline characteristics of the study cohort
Smoking categories
Never smokers Former smokers Current smokers
Characteristics (n=37023) (n=18260) (n=15404)
Person-years 395 603 192 284 163 946
Age (median years) 48 48 48
Body Mass Index (median kg m
72) 24.1 24.0 23.6
Education (% post-secondary) 28.8 34.4 23.4
Oral contraceptive use (%) 54.5 63.7 62.9
Hormone replacement therapy (%) 21.4 22.7 25.3
Menopausal status (% postmenopausal) 41.0 39.9 44.0
Parity (mean number of children) 2.5 2.3 2.3
Vigorous physical activity (mean hours days
71) 1.1 1.1 1.2
Alcohol (median grams day
71) 1.5 4.1 3.7
Table 2 Rate ratios for endometrial cancer in relation to cigarette smoking
Adjusted for
Cases/Persons-years Age Age, Quetelet’s index Multivariate
a
Smoking status
Never-smokers 228/395 603 1.0 (referent) 1.0 (referent) 1.0 (referent)
Ex-smokers 106/192 284 0.98 (0.78–1.24) 0.99 (0.79–1.25) 0.99 (0.78–1.25)
Current smokers 69/163 946 0.77 (0.59–1.00) 0.82 (0.62–1.07) 0.83 (0.63–1.09)
aMultivariate models included age in 5-year age groups, Quetelet’s index (quartiles), education level (less than high school, high
school, and university), vigorous physical activity (hours per day in tertiles, and ‘missing’), hormone replacement therapy
(never+four levels of duration), oral contraceptive use (never + four levels of duration), menopausal status (pre, peri, post),
parity (nulliparous, and tertiles), and alcohol consumption (tertiles, and ’missing‘).
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lating oestrogen levels may consequently reduce the risk of
this malignancy (Baron, 1984; Baron et al, 1990). In this
regard, it has been hypothesised that smoking might be inver-
sely related to levels of circulating oestrogen (Jensen et al,
1985; Baron et al, 1990; Weiderpass and Baron, 2001).
Supporting this hypothesis are studies that have shown that
smoking is associated with increased risk of osteoporosis
(Jensen et al, 1985; Jensen and Christiansen, 1988) and may
attenuate the reduction in serum total and low-density lipo-
protein cholesterol associated with exogenous hormone use
(HRT) (Jensen and Christiansen, 1988). However, plasma
levels of oestradiol and oestrone have not been signiﬁcantly
associated with smoking either in pre- or postmenopausal
women in several studies (Khaw et al, 1988; Longcope and
Johnston, 1988; Baron et al, 1990; Cassidenti et al, 1992),
although reduced levels of oestrone and oestradiol in current
smokers compared with ex-smokers or never smokers have
been noted (Austin et al, 1993), especially among women
using HRT (Jensen et al, 1985; Cassidenti et al, 1990). Para-
doxically, these studies have also found higher circulating
levels of androstenedione among current than former smokers
(Cassidenti et al, 1990; Austin et al, 1993), especially among
women who were postmenopausal and/or obese.
Cigarette smoking has been associated inversely with endo-
metrial cancer risk in both population-based (Tyler et al,
1985; Franks et al, 1987; Lawrence et al, 1987, 1989; Elliott
et al, 1990; Rubin et al, 1990; Brinton et al, 1993; Newcomer
et al, 2001; Weiderpass and Baron, 2001) and hospital-based
(Williams and Horm, 1977; Baron, 1984; Lesko et al, 1985;
Levi et al, 1987; Stockwell and Lyman, 1987; Koumantaki et
al, 1989; Austin et al, 1993) case–control studies, although
in several studies of both types the observed associations were
weak and statistically non-signiﬁcant. Of the two previous
prospective studies of endometrial cancer incidence, one found
a small, statistically non-signiﬁcant increased risk with
‘current’ smoking (Engeland et al, 1996), and the results of
the other (Terry et al, 1999) were also equivocal; both,
however, were small with 36 and 12 cases respectively among
current smokers.
In the previous examinations of risk in relation to smoking
intensity (Lesko et al, 1985; Lawrence et al, 1987, 1989; Levi
et al, 1987; Stockwell and Lyman, 1987; Brinton et al, 1993;
Terry et al, 1999; Weiderpass and Baron, 2001), the highest
category was generally at least 15 cigarettes per day or more
and generally showed a 25–60% decreased risk among ‘current’
smokers but not among ex-smokers. In addition to smoking
intensity, two studies (Brinton et al, 1993; Weiderpass and
Baron, 2001) also examined risk in relation to smoking dura-
tion of up to 40 years or more. In contrast with our
ﬁndings, smoking duration was more strongly associated with
endometrial cancer risk than smoking intensity in those studies.
However, the fact that the various smoking measures are often
correlated with each other (as in our data) complicates the
differentiation of their independent effects. In general, smokers
of high intensity also tend to be smokers of long duration,
tending to have commenced smoking at an early age. A non-
signiﬁcant reduced risk has been reported with early age at start
of smoking (Brinton et al, 1993) as we also found; this aspect
was not examined in other studies.
Several studies have shown a reduced endometrial cancer
risk with current smoking that is stronger among, or limited
to, postmenopausal women (Smith et al, 1984; Lesko et al,
1985; Brinton et al, 1993; Weiderpass and Baron, 2001),
women using HRT (Weiss et al, 1980; Franks et al, 1987;
Levi et al, 1987), and those who are obese (Lawrence et al,
1987; Brinton et al, 1993). However, as with our study, other
studies have failed to demonstrate signiﬁcant differences
according to menopausal status (Lawrence et al, 1987; Levi
et al, 1987), obesity (Levi et al, 1987), or HRT use (Lawr-
ence et al, 1987; Brinton et al, 1993; Weiderpass and
Baron, 2001), and at least three studies (Lawrence et al,
1987; Brinton et al, 1993; Weiderpass and Baron, 2001) found
stronger inverse associations among non-users of HRT. Thus,
whether factors related to circulating oestrogen levels modify
the association between smoking and endometrial cancer risk
remains unclear. It is interesting that we found smoking asso-
ciated with risk only among parous women, although the
number of cases among nulliparous women was relatively
small. As in our study, previous studies have found a lower
risk of endometrial cancer among parous than nulliparous
women (Terry et al, 1999; Weiderpass and Baron, 2001),
which may be due to signiﬁcantly lower circulating oestrogen
levels in the former (Bernstein et al, 1985).
In summary, we found that current smoking was associated
with a reduced risk of endometrial cancer as in most previous
case–control studies; risk was observed primarily among women
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Table 3 Adjusted
a rate ratios for endometrial cancer in relation to cigar-
ette smoking by smoking status
Smoking measure Case/Person–years RR (95% CI)
Years smoked
Never-smokers 228/395 603 1.0 (referent)
Ex-smokers
1–20 58/127 558 0.88 (0.65–1.18)
420 45/61 004 1.12 (0.81–1.56)
P for trend
b 0.66
Current smokers
1–20 12/30 063 0.89 (0.50–1.60)
420 56/130 078 0.82 (0.60–1.10)
P for trend
b 0.19
Cigarettes/Day
Never-smokers 228/395 603 1.0 (referent)
Ex-smokers
1–20 63/108 700 1.04 (0.78–1.39)
420 40/77 863 0.91 (0.64–1.28)
P for trend
b 0.64
Current smokers
1–20 39/68 186 1.09 (0.77–1.55)
420 29/92 943 0.62 (0.42–0.92)
P for trend
b 0.03
Pack-years
c
Never-smokers 228/395 603 1.0 (referent)
Ex-smokers
1–20 69/137 339 0.95 (0.72–1.25)
420 31/45 565 1.04 (0.71–1.52)
P for trend
b 0.97
Current smokers
1–20 32/65 456 0.99 (0.68–1.45)
420 35/91 868 0.73 (0.51–1.05)
P for trend
b 0.10
Years since cessation of smoking
d
Never-smokers 228/395 603 1.0 (referent)
1–9 21/34 403 1.13 (0.71–1.79)
10–19 15/25 165 1.08 (0.64–1.83)
20+ 62/122 036 0.90 (0.67–1.20)
P for trend
b 0.54
aMutlivariate models included age in 5 year age groups, Quetelet’s index (quartiles),
education level (less than high school, high school, and university), vigorous physical
activity (hours per day in tertiles, and ‘missing’), hormone replacement therapy
(never+four levels of ruation), oral contraceptive use (never + four levels of dura-
tion), menopausal status (pre, peri, post), parity (nulliparous, and tertiles), and
alcohol consumption (tertiles, and ’P-values are from two-sided tests.
cPack
years=(cigarettes smoked per day/20 6 years smoked.
dEx-smokers only.
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relatively long time, but the association was not observed among
former smokers. The mechanisms underlying this association
remain unclear.
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Table 4 Adjusted
a rate ratios for endometrial cancer by menopausal status, exo-
genous hormone use, parity, and obesity.
Smoking measure
Cigarettes/Day Premenopausal Postmenopausal
Current smokers
1–20 1.00 (0.59–1.70) 1.12 (0.68–1.86)
420 0.73 (0.43–1.26) 0.59 (0.33–1.06)
P for trend
b 0.28 0.11
Cigarettes/Day HRT
c negative history HRT
c positive history
Current smokers
1–20 0.88 (0.56–1.39) 16.5 (0.94–2.91)
420 0.62 (0.39–0.99) 0.64 (0.31–1.30)
P for trend
b 0.04 0.37
Cigarettes/Day OC
c negative history OC
c positive history
Current smokers
1–20 1.43 (0.92–2.20) 0.79 (0.44–1.42)
420 0.67 (0.39–1.15) 0.61 (0.34–1.08)
P for trend
b 0.30 0.08
Cigarettes/Day Nulliparous Parous
Current smokers
1–20 1.50 (0.77–2.91) 1.09 (0.73–1.65)
420 0.97 (0.50–1.88) 0.59 (0.36–0.96)
P for trend
b 0.94 0.05
Cigarettes/Day Non-obese
d Pre-obese
d Obese
d
Current smokers
1–20 1.16 (0.71–1.88) 1.07 (0.51–2.26) 1.08 (0.55–2.12)
420 0.54 (0.29–0.99) 0.77 (0.38–1.59) 0.65 (0.31–1.36)
P for trend
b 0.07 0.52 0.29
aMultivariate models included age in 5 year age groups, Quetelet’s index (quartiles), education
level (less than high school, high school, and university), vigorous physical activity (hours per
day in tertiles, and ‘missing’), hormone replacement therapy (never + four levels of dura-
tion), oral contraceptive use (never + four levels of duration), menopausal status (pre, peri,
post), parity (nulliparous, and tertiles), and alcohol consumption (tertiles, and ’missing‘).
bAll
P-values are from two-sided tests.
cOC – oral contraceptive use HRT – hormone replace-
ment therapy.
dNon-obese: BMI525.0 kg m
72; Pre-obese: BMI 25.0–30 kg
72; Obese: BMI
530.0 kg m
72.
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